An effect on CD4+ T-cells was also observed in multiple myeloma patients wherein treatment with DCs and cytokine-induced killer cells (CIK) combined with bortezomib and dexamethasone improved CD4+/CD8+ T-cell ratios compared to baseline and treatment with chemotherapy alone (67). Here, CD4 is linked to AL amyloidosis.